HarmonyFidelisHarmonyFidelis
Login
NewsMajor ProjectsActorsAcademy
Back to Pulse

Neuralink & brain-machine interfaces

PulseEarly clinical trials

Concrete tracking of the transhumanism axis: implants, robotic surgery, clinical protocols and long-term safety.

Tracking objective

Establish a stable bidirectional interface for functional restoration, with a safe and reproducible protocol.

Overall progress36%

Update frequency: Monthly

Tracked systems

  • Intracranial implant (electronics + encapsulation)
  • High-precision surgical insertion robot
  • Neural signal firmware
  • Intent decoding pipeline
  • Clinical patient follow-up protocol

Current focus

  • Signal quality over extended duration
  • Reducing surgical procedure time
  • Patient-interface learning loop

Risks / constraints

  • Signal/electrode degradation over time
  • Ethical and regulatory constraints across jurisdictions
  • Software security and cybersecurity of the interfaces

Detailed technical axes

Implant evolution

Hardware maturity: miniaturization, electrical stability, biocompatible enclosure.

  • Versioning of implantable modules
  • Thermal stability and power consumption
  • Biological tolerance over long cycles

Neuro-signal pipeline

From capture to real-time decoding with actionable feedback.

  • Signal-to-noise ratio per session
  • Intent decoding latency
  • Accuracy of the generated commands

Applied transhumanism framework

Moving from research to concrete uses under strong ethical constraints.

  • Delineating therapy vs augmentation
  • Security audits and neural data governance
  • Clinical and societal acceptability

Feuille d'évolution

Validée

Phase A — Preclinical and robotics

2019-2024100%
  • Validation of robotic insertion precision
  • Signal readout chain stabilized in the lab
  • Intraoperative safety framework consolidated
En cours

Phase B — Early human trials

2025-202636%
  • Tracking the first clinical protocols
  • Measuring signal quality in real-world use
  • Firmware adjustments and patient calibrations
Prochaine

Phase C — Clinical standardization

2027+12%
  • Multi-center reproducibility
  • Cyber-biomedical safety standards
  • Broadened use cases (mobility, communication)
Retour à la liste des suivisVoir le domaine lié